Skip to content

A feasibility randomised controlled trial comparing VR-assisted nature therapy with an established online stress management intervention for individuals experiencing stress and anxiety

VR-assisted nature therapy versus online stress management: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN59787438
Enrollment
60
Registered
2026-07-27
Start date
2024-11-08
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild-to-moderate levels of stress or anxiety Mental and Behavioural Disorders

Interventions

Participants were allocated to either the Thrive Inside intervention group or the active control group after informed consent and enrolment. Microsoft Excel was used to generate a random allocation se

Sponsors

EarthscapeVR LTD
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 66 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-66 years 2. Able to provide written informed consent 3. Able to understand English sufficiently to provide written informed consent and understand the written content of the course (alternative language versions are planned for future versions of both the online course and VR content 4. Are aware of ongoing symptoms of mild-moderate anxiety or stress, e.g., over-worrying, nervousness, irritability, mood swings, difficulty concentrating, feeling overwhelmed, exhaustion, negative thoughts, avoidance or withdrawal from usual activities, appetite changes, sleep disturbances, and/or changes in routine 5. Have access to a laptop, mobile phone, or tablet with an internet connection to participate in the online course. The course is designed to be user-friendly and accessible across multiple devices, promoting greater inclusivity

Exclusion criteria

Exclusion criteria: 1. No history of serious self-reported psychiatric or medical conditions 2. No current self-reported serious psychiatric symptoms, such as psychosis or eating disorders 3. No significant issues with vision and/or hearing loss 4. A diagnosis of, or chronic symptoms related to, anxiety disorders such as social anxiety, agoraphobia, health anxiety, panic disorder, or obsessive-compulsive disorder

Design outcomes

Primary

MeasureTime frame
Perceived stress measured using the Perceived Stress Scale (PSS-10) at baseline Week 0, mid-intervention (around weeks 3 - 6), and post-intervention (around week 14);Anxiety symptoms measured using Generalized Anxiety Disorder-7 (GAD-7) at baseline Week 0, mid-intervention (around weeks 3 - 6), and post-intervention (around week 14)

Secondary

MeasureTime frame
Mental well-being measured using the Warwick–Edinburgh Mental Well-being Scale (WEMWBS) at baseline Week 0, mid-intervention (around weeks 3 - 6), and post-intervention (around week 14);Life satisfaction measured using the Satisfaction With Life Scale (SWLS) at baseline Week 0, mid-intervention (around weeks 3 - 6), and post-intervention (around week 14);Nature connectedness measured using the Nature Relatedness Scale-6 (NR-6) at baseline Week 0, mid-intervention (around weeks 3 - 6), and post-intervention (around week 14)

Countries

England, United Kingdom

Contacts

Public ContactAnnahita Nezami
annahita@earthscapevr.com-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 25, 2026